SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001206774-04-000313
Filing Date
2004-04-12
Accepted
2004-04-12 12:01:03
Documents
3
Period of Report
2004-05-12
Effectiveness Date
2004-04-12

Document Format Files

Seq Description Document Type Size
1 d14366.htm DEF 14A 289184
3 GRAPHIC biocrystlogo.jpg GRAPHIC 13092
4 GRAPHIC d14366line.jpg GRAPHIC 46500
  Complete submission text file 0001206774-04-000313.txt   350499
Mailing Address 2190 PARKWAY LAKE DR BIRMINGHAM AL 35244
Business Address 2190 PKWY LAKE DR BIRMINGHAM AL 35244 2054444600
BIOCRYST PHARMACEUTICALS INC (Filer) CIK: 0000882796 (see all company filings)

IRS No.: 621413174 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-23186 | Film No.: 04727912
SIC: 2836 Biological Products, (No Diagnostic Substances)